Cargando…
Cross-Protection of Hepatitis B Vaccination among Different Genotypes
Hepatitis B (HB) vaccination is the most effective method for preventing HB virus (HBV) infection. Universal HB vaccination containing recombinant HB surface antigens (HBsAg) is recommended. Our data revealed that human monoclonal HB surface antibody (anti-HBs) from individuals inoculated with genot...
Autores principales: | Inoue, Takako, Tanaka, Yasuhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563454/ https://www.ncbi.nlm.nih.gov/pubmed/32824318 http://dx.doi.org/10.3390/vaccines8030456 |
Ejemplares similares
-
Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B
por: Watanabe, Takehisa, et al.
Publicado: (2021) -
Novel biomarkers for the management of chronic hepatitis B
por: Inoue, Takako, et al.
Publicado: (2020) -
The Role of Hepatitis B Core-Related Antigen
por: Inoue, Takako, et al.
Publicado: (2019) -
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
por: Inoue, Takako, et al.
Publicado: (2023) -
Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi
por: Baudi, Ian, et al.
Publicado: (2020)